ViVex Biomedical Raising $5.5 Million to Develop Implant Technology
7/19/2013 8:04:49 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A biomedical startup that focuses on implant technology and stem cell therapies is raising $5.5 million, according to a Securities & Exchange Commission filing. Vivex Biomedical Inc., is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage Inducible) cells.
Help employers find you! Check out all the jobs and post your resume.
comments powered by